| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BJS.10457 |
| P698 | PubMed publication ID | 28181674 |
| P50 | author | Geir Egil Eide | Q64766944 |
| P2093 | author name string | A Horn | |
| A Viste | |||
| H Sorbye | |||
| J-H Angelsen | |||
| I M Løes | |||
| P2860 | cites work | Immeasurable time bias in observational studies of drug effects on mortality. | Q53039067 |
| Effect of specialist decision-making on treatment strategies for colorectal liver metastases. | Q53103788 | ||
| Liver resection of colorectal metastases in elderly patients. | Q53180067 | ||
| Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. | Q53534960 | ||
| Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. | Q53662655 | ||
| Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer | Q57258025 | ||
| Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies | Q24651894 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus | Q26784531 | ||
| Meta-analysis of colorectal cancer follow-up after potentially curative resection | Q28069831 | ||
| FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study | Q28189472 | ||
| Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer | Q28308193 | ||
| Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer | Q30278725 | ||
| Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness | Q33394103 | ||
| Competing risk regression models for epidemiologic data | Q33459711 | ||
| Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 | ||
| Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. | Q34005870 | ||
| Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway | Q34311173 | ||
| Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma | Q34503734 | ||
| Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. | Q34625619 | ||
| Competing risks in epidemiology: possibilities and pitfalls | Q36093739 | ||
| Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey. | Q36244515 | ||
| Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). | Q36278103 | ||
| Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases | Q36344123 | ||
| Bringing unresectable liver disease to resection with curative intent | Q36991602 | ||
| Expanding criteria for resectability of colorectal liver metastases | Q37075581 | ||
| Repeat hepatectomy for recurrent colorectal metastases | Q38089673 | ||
| Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease | Q38207240 | ||
| Management of colorectal cancer presenting with synchronous liver metastases | Q38217004 | ||
| Selection for surgery and survival of synchronous colorectal liver metastases; a nationwide study. | Q40172679 | ||
| Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry. | Q40572062 | ||
| Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection | Q43798315 | ||
| Major liver resections in the elderly-is an aggressive approach justified? | Q44040034 | ||
| Surgical management and outcomes of colorectal cancer liver metastases | Q44651017 | ||
| Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer. | Q45852233 | ||
| A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer | Q46798669 | ||
| Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. | Q51043898 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Norway | Q20 |
| liver metastasis | Q18967325 | ||
| P304 | page(s) | 580-589 | |
| P577 | publication date | 2017-02-09 | |
| P1433 | published in | British Journal of Surgery | Q4970212 |
| P1476 | title | Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway | |
| P478 | volume | 104 |
| Q90479455 | Association between the lymph node ratio and hepatic tumor burden: importance for resectable colorectal liver metastases? |
| Q90295035 | Contemporary practice and short-term outcomes after liver resections in a complete national cohort |
| Q53699565 | Disparities in resection of hepatic metastases in colon cancer. |
| Q92263525 | Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition |
Search more.